-
Anker faces $20.1 million damages verdict in NEC surveillance patent dispute
Read more: Anker faces $20.1 million damages verdict in NEC surveillance patent disputeNEC has won a $20.1 million jury verdict against Anker over patents covering video surveillance technology. The Texas jury found infringement of three valid patents.
-
Certain disgruntled member states might leave the UPC system — or block not only new judicial appointments but also all 2029 reappointments
Read more: Certain disgruntled member states might leave the UPC system — or block not only new judicial appointments but also all 2029 reappointmentsThe scenario of a more or less orderly exit of contracting member states is still not likely, but far from inconceivable. It would yet be easier to make happen than amending the UPCA.
-
Flinn sues OpenAI and Anthropic over five neural network patents in Delaware: first major patent campaign targeting core AI software
Read more: Flinn sues OpenAI and Anthropic over five neural network patents in Delaware: first major patent campaign targeting core AI softwareTwo parallel Delaware complaints accuse ChatGPT and Claude of infringing five patents on attention-based neural networks that carry more than 1,000 issued claims, as both AI companies prepare their IPOs.
-
China refines its Hatch-Waxman counterpart as Beijing IP Court highlights nine pharma patent cases
Read more: China refines its Hatch-Waxman counterpart as Beijing IP Court highlights nine pharma patent casesNine selected Beijing IP Court cases clarify pharmaceutical patent protection and the operation of China’s Hatch-Waxman counterpart, addressing claim scope, the boundaries of linkage litigation and generic applicants’ declarations and evidence.
-
Access Advance to slash discounts available to dual HEVC and VVC licensees who sign up to bridging agreement from next year
Read more: Access Advance to slash discounts available to dual HEVC and VVC licensees who sign up to bridging agreement from next yearThose who sign the Multi Codec Bridging Agreement on or before December 31, 2026 could still get an effective royalty discount of up to 50%.
-
InterDigital Chief Legal Officer Josh Schmidt: antitrust has “limited role” in SEP FRAND disputes
Read more: InterDigital Chief Legal Officer Josh Schmidt: antitrust has “limited role” in SEP FRAND disputesIn an exclusive interview with ip fray, Mr. Schmidt discusses InterDigital’s global patent infringement case against Disney, his views on the diverging approaches of different courts and their impact on SEP litigation, the role of antitrust in SEP FRAND disputes, and using arbitration versus mediation as alternative dispute resolution mechanisms.
-
Brazilian court gives weight to German FRAND decisions in IP Bridge v. Transsion
Read more: Brazilian court gives weight to German FRAND decisions in IP Bridge v. TranssionA court in Rio has rejected a fresh economic examination of Via Licensing Alliance’s AVC patent pool licensing terms, relying on earlier German judgments and Brazilian appellate authority in a decision highlighting the growing influence of prior FRAND rulings.
-
UPC Hague LD finds Pfizer/BioNTech’s Comirnaty infringes GSK liposome patent; grants pan-European injunction but defers enforcement
Read more: UPC Hague LD finds Pfizer/BioNTech’s Comirnaty infringes GSK liposome patent; grants pan-European injunction but defers enforcementThe UPC Hague LD upheld 12 claims of GSK’s liposome patent, finding that Pfizer and BioNTech’s Comirnaty vaccine infringes six of them. It revoked one medical-use claim for insufficiency and granted a pan-European injunction, subject to deferred enforcement.
Follow Us
Latest Articles
- Anker faces $20.1 million damages verdict in NEC surveillance patent dispute
- Certain disgruntled member states might leave the UPC system — or block not only new judicial appointments but also all 2029 reappointments
- Flinn sues OpenAI and Anthropic over five neural network patents in Delaware: first major patent campaign targeting core AI software
- China refines its Hatch-Waxman counterpart as Beijing IP Court highlights nine pharma patent cases
- Access Advance to slash discounts available to dual HEVC and VVC licensees who sign up to bridging agreement from next year